DOCSLIB.ORG

Biospherix Customer Publication List Journal Articles 1985 – December 2020

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biospherix Customer Publication List Journal Articles 1985 – December 2020 BioSpherix Customer Publication List Journal Articles 1985 – December 2020 We currently have 3019 citations in customer research article publications References by Year 2020 [1-293] 2019 [294-519] 2018 [520-769] 2017 [770-1026] 2016 [1027-1257] 2015 [1258-1518] 2014 [1519-1743] 2013 [1744-1957] 2012 [1958-2147] 2011 [2148-2293] 2010 [2294-2440] 2009 [2441-2561] 2008 [2562-2652] 2007 [2653-2733] 2006 [2734-2791] 2005 [2792-2849] 2004 [2850-2887] 2003 [2888-2926] 2002 [2927-2948] 2001 [2949-2959] 2000 [2960-2967] 1999 [2968-2971] 1998 [2972-2982] 1997 [2983-2987] 1996 [2988-2991] 1995 [2992, 2993] 1994 [2994-2996] 1993 [2997] 1992 [2998, 2999] 1990 [3000, 3001] 1989 [3002-3007] 1988 [3008-3010] 1987 [3011-3013] 1986 [3014-3017] 1985 [3018, 3019] References 1. Abu-El-Rub, E., et al., Hypoxia-induced increase in Sug1 leads to poor post- transplantation survival of allogeneic mesenchymal stem cells. FASEB J, 2020. 34(9): p. 12860-12876. 2. Abu-El-Rub, E., et al., Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells. Cell Death Dis, 2020. 11(6): p. 419. 3. Adams, K.V., et al., Constraint-induced movement therapy promotes motor recovery after neonatal stroke in the absence of neural precursor activation. Eur J Neurosci, 2020. n/a(n/a). 4. Aghajanian, A., et al., Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart. J Mol Cell Cardiol, 2020. 150: p. 1-11. 5. Ahmed, F., et al., Meprin-beta activity modulates the beta-catalytic subunit of protein kinase A in ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol, 2020. 318(5): p. F1147-F1159. 6. Al Khazal, F., et al., Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency. FASEB J, 2020. 7. Allan, K.C., et al., Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function. Cell Stem Cell, 2020. 8. Alleboina, S., et al., Feature article: Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetes. Exp Biol Med (Maywood), 2020. 245(9): p. 785-796. 9. Amgalan, D., et al., A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy. Nat Cancer, 2020. 1(3): p. 315-328. 10. Amin, S., et al., Efficacy of Aflibercept Treatment and its Effect on the Retinal Perfusion in the Oxygen-Induced Retinopathy Mouse Model of Retinopathy of Prematurity. Ophthalmic Res, 2020. 11. Aravamuthan, B.R., et al., Sex may influence motor phenotype in a novel rodent model of cerebral palsy. Neurobiol Dis, 2020. 134: p. 104711. 12. Arita, M., et al., Licochalcone A Inhibits BDNF and TrkB Gene Expression and Hypoxic Growth of Human Tumor Cell Lines. Int J Mol Sci, 2020. 21(2): p. 506. 13. Ashley, S.L., et al., Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice. Sci Transl Med, 2020. 12(556): p. eaau9959. 14. Bachmann, J., et al., Ischemia-Like Stress Conditions Stimulate Trophic Activities of Adipose-Derived Stromal/Stem Cells. Cells, 2020. 9(9). 15. Badran, M., et al., Fecal microbiota transplantation from mice exposed to chronic intermittent hypoxia elicits sleep disturbances in naive mice. Exp Neurol, 2020. 334: p. 113439. 16. Bagati, A., et al., Novel combination therapy for melanoma induces apoptosis via a gap junction positive feedback mechanism. Oncotarget, 2020. 11(37): p. 3443-3458. 17. Barbosa, D.M., et al., Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis. Sci Rep, 2020. 10(1): p. 4888. 18. Bats, M.L., et al., Therapies targeting Frizzled-7/beta-catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model. FASEB J, 2020. 34(1): p. 1288-1303. 19. Beer, Y., et al., 3β-Diol Attenuates COX-2 Levels in a Neonatal In-Vivo and In- Vitro Ischemic Injury Rodent and Human Model. The FASEB Journal, 2020. 34(S1): p. 1-1. 20. Beharry, K.D., et al., Combination Antioxidant/NSAID Therapies and Oral/Topical Ocular Delivery Modes for Prevention of Oxygen-Induced Retinopathy in a Rat Model. Nutrients, 2020. 12(7). 21. Bennett, A.D. and C.F. Rakocinski, Respiration by the Opportunistic Spionid Polychaete Streblospio gynobranchiata during Adjustment to and Recovery from Moderate Hypoxia. Diversity, 2020. 12(2): p. 73. 22. Bermudez, D., et al., Increased hypoxic proliferative response and gene expression in erythroid progenitor cells of Andean highlanders with chronic mountain sickness. Am J Physiol Regul Integr Comp Physiol, 2020. 318(1): p. R49-R56. 23. Bharat, A., et al., High CO2 Levels Impair Lung Wound Healing. Am J Respir Cell Mol Biol, 2020. 63(2): p. 244-254. 24. Bhedi, C.D., et al., Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling. FASEB J, 2020. 34(1): p. 930-944. 25. Bikou, O., et al., Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model. J Vis Exp, 2020(160). 26. Bittencourt-Silva, P.G., et al., Postnatal intermittent hypoxia enhances phrenic and reduces vagal upper airway motor activities in rats by epigenetic mechanisms. Exp Physiol, 2020. 105(1): p. 148-159. 27. Brackley, A.D., M.A. Andrade, and G.M. Toney, Intermittent hypercapnic hypoxia induces respiratory hypersensitivity to fentanyl accompanied by tonic respiratory depression by endogenous opioids. J Physiol, 2020. 598(15): p. 3239-3257. 28. Bretz, C.A., et al., Signaling Through the Erythropoietin Receptor Affects Angiogenesis in Retinovascular Disease. Invest Ophthalmol Vis Sci, 2020. 61(10): p. 23. 29. Bretz, C.A., et al., Erythropoietin Receptor Signaling Supports Retinal Function after Vascular Injury. Am J Pathol, 2020. 190(3): p. 630-641. 30. Cahill, L.S., et al., Sex differences in modulation of fetoplacental vascular resistance in growth-restricted mouse fetuses following betamethasone administration: comparisons with human fetuses. Am J Obstet Gynecol MFM, 2020. 31. Casalino-Matsuda, S.M., et al., Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1. J Immunol, 2020. 205(2): p. 489-501. 32. Cavallo, D., et al., Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors. Neuropharmacology, 2020. 162: p. 107810. 33. Chao, C.M., et al., Failure to Down-Regulate miR-154 Expression in Early Postnatal Mouse Lung Epithelium Suppresses Alveologenesis, with Changes in Tgf-beta Signaling Similar to those Induced by Exposure to Hyperoxia. Cells, 2020. 9(4). 34. Chaubey, S., et al., alpha1,3-Fucosyltransferase-IX, an enzyme of pulmonary endogenous lung stem cell marker SSEA-1, alleviates experimental bronchopulmonary dysplasia. Pediatr Res, 2020. 35. Chavali, M., et al., Wnt-Dependent Oligodendroglial-Endothelial Interactions Regulate White Matter Vascularization and Attenuate Injury. Neuron, 2020. 108(6): p. 1130-1145 e5. 36. Chen, H., et al., NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener, 2020. 15(1): p. 26. 37. Chen, H., et al., Ghrelin suppresses migration of macrophages via inhibition of ROCK2 under chronic intermittent hypoxia. J Int Med Res, 2020. 48(6): p. 300060520926065. 38. Chen, J., et al., A Protective Role of SOD1 Overexpression in Central Mediation of Bradycardia Following Chronic Intermittent Hypoxia in Mice. Am J Physiol Regul Integr Comp Physiol, 2020. 0(0): p. null. 39. Chen, J., et al., A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization. Angiogenesis, 2020. 40. Chen, X., et al., Pharmacokinetics of Inter-Alpha Inhibitor Proteins and Effects on Hemostasis After Hypoxic-Ischemic Brain Injury in Neonatal Rats. Curr Pharm Des, 2020. 26(32): p. 3997-4006. 41. Cho, H., et al., iPSC-derived endothelial cell response to hypoxia via SDF1a/CXCR4 axis facilitates incorporation to revascularize ischemic retina. JCI Insight, 2020. 5(6). 42. Clapper, E., G. Di Trapani, and K.F. Tonissen, The regulation of bcr-abl in hypoxia is through the mTOR pathway. Leukemia & Lymphoma, 2020: p. 1-12. 43. Coelho, N.R., et al., First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia. Pharmacol Res, 2020. 159: p. 104869. 44. Cohen, E.B., R.C. Geck, and A. Toker, Metabolic pathway alterations in microvascular endothelial cells in response to hypoxia. PLoS One, 2020. 15(7): p. e0232072. 45. Compton, S.L.E., et al., Adaptation of metabolism to multicellular aggregation, hypoxia and obese stromal cell incorporation as potential measure of survival of ovarian metastases. Exp Cell Res, 2020. 399(1): p. 112397. 46. Coucha, M., et al., Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents. Vascul Pharmacol, 2020. 131: p. 106761. 47. Coy, R., et al., Combining in silico and in vitro models to inform cell seeding strategies in tissue engineering. J R Soc Interface, 2020. 17(164): p. 20190801. 48. Coyle, R.C., et al., Targeting HIF‐α for robust prevascularization of human cardiac organoids. Journal of Tissue Engineering and Regenerative Medicine, 2020. n/a(n/a). 49. Cubillos-Zapata, C., et al., Differential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation. Sleep, 2020. 43(5). 50. Cubillos-Zapata, C., et al., Proangiogenic factor midkine is increased in melanoma patients with sleep apnea and induces tumor cell proliferation. FASEB J, 2020. 34(12): p. 16179-16190. 51. Cui, T.X., et al., Lung CD103+ Dendritic Cells and Clec9a Signaling Are Required for Neonatal Hyperoxia-Induced Inflammatory Responses to Rhinovirus Infection. Am J Physiol Lung Cell Mol Physiol, 2020. 52. Dalal, S., et al., Exogenous ubiquitin attenuates hypoxia/reoxygenation-induced cardiac myocyte apoptosis via the involvement of CXCR4 and modulation of mitochondrial homeostasis.
Load more

Recommended publications
  • Microgram Journal, Vol 3, Number 2
    MICROGRAM Laboratory Operations Division Office Of Science And Drug Abuse Prevention BUREAU OF NARCOTICS & DANGEROUS DRUGS / U.S. DEPARTMENT OF JUSTICE / WASHINGTION, D.C. 20537 Vol.III, No. 2 March-April, 1970 STP (4-Methyl-2,5-dimethoxyamphetamine) hydrochloride was found coating the inside of capsules sent to BNDDfrom Germany. The capsules were clear, hard gelatin, standard shape size No. o. Average weight was 114 milligrams. Each capsule had a white crystalline coating on inner surface of capsule body. Apparently a measu~ed amount of solution had been placedin the cap·sule body, after which it was rotated to spread the solution on the inner surface. The substance contained 8. 7 milli­ grams STP (DOM)HCl per ca·psule. · These were the first STP capsules of this type seen by our laboratory. A few years ago, capsules were ob­ tained in the U.S. similarly coated with LSD. STP (Free Base) on laboratory filter paper, also from Germany, was seen for the first time in our laboratory. The STP spots, containing approxi­ mately 8 miliigrams STP base each, were 5/8 to 3/4 inch in diameter. The paper was 1\ inches square. Phencyclidine (Free Base) was recently analyzed on parsley leaves. Called "Angel DUst, 11 the phencyclidine on two samples of leaves was 2.6% and 3.6%. Approximately thirty pounds of 94% pure powder was also analyzed. (For identification of phencyclidine base, see Microgram, II, 1, p.3 (Jan 1969). IMITATIONSof well-known drug products are examined frequently in our Special Testing and Research Laboratory. Many of these are well made preparations and closely resemble the imitated product.
    [Show full text]
  • United States Patent [191 [11] Patent Number: 4,758,639 Koyanagi Et Al
    United States Patent [191 [11] Patent Number: 4,758,639 Koyanagi et al. [45] Date of Patent: Jul. 19, 1988 [54] PROCESS FOR PRODUCTION OF VINYL [56] References Cited POLYMER . U.S. PATENT DOCUMENTS [75] Inventors: Shunichi Koyanagi, Yokohama; 3,923,765 12/1975 Goetze et al. ....................... .. 526/62 Hajime Kutamura, Ichihara; 4,049,895 9/1977 McOnie et al. ..... .. 526/62 Toshihide Shimizu; Ichiro Kaneko, 4,539,230 9/ 1985 Shimizu et al. ................. .. 526/62 X both of Ibaraki, all of Japan Primary Examiner-Joseph L. Schofer Assistant Examiner-F. M. Teskin [73] Assignee: Shin-Etsu Chemical Co., Ltd., Tokyo, Attorney, Agent, or Firm—0blon, Fisher, Spivak, Japan McClelland & Maier [21] Appl. No.: 94,020 [57] ABSTRACT [22] Filed: Sep. 3, 1987 A process for production of a vinyl polymer by suspen sion polymerization or emulsion polymerization of at Related US. Application Data least one kind of vinyl monomer in an aqueous medium is disclosed. [63] Continuation of Ser. No. 765,803, Aug. 15, 1985, aban In this process, the polymerization is carried out in a cloned. polymerizer, the inner wall surface and portions of the [30] Foreign Application Priority Data auxiliary equipment thereof which may come into contact with the monomer during polymerization hav Aug. 17, 1984 [JP] Japan ........ .. .. 59471045 ing a surface roughness of not greater than 5 pm and Aug. 17, 1984 [JP] Japan .............................. .. 59-171046 being previously coated with a scaling preventive com [51] Int. Cl.‘ ......................... .. C08F 2/18; C08F 2/22; prising at least one selected from dyes, pigments and CO8F 2/44 aromatic or heterocyclic compounds having at least 5 [52] US.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,393,221 B2 W (45) Date of Patent: Jul.19, 2016
    USOO9393221B2 (12) United States Patent (10) Patent No.: US 9,393,221 B2 W (45) Date of Patent: Jul.19, 2016 (54) METHODS AND COMPOUNDS FOR FOREIGN PATENT DOCUMENTS REDUCING INTRACELLULAR LIPID STORAGE WO WO2007096,251 8, 2007 OTHER PUBLICATIONS (75) Inventor: Sean Wu, Brookline, MA (US) Onyesom and Agho, Asian J. Sci. Res., Oct. 2010, vol. 4, No. 1, p. (73) Assignee: THE GENERAL, HOSPITAL 78-83. CORPORATION, Boston, MA (US) Davis et al., Br J Clin Pharmacol., 1996, vol. 4, p. 415-421.* Schweiger et al., Am J Physiol Endocrinol Metab, 2009, vol. 279, E289-E296. (*) Notice: Subject to any disclaimer, the term of this Maryam Ahmadian et al., Desnutrin/ATGL is regulated by AMPK patent is extended or adjusted under 35 and is required for a brown adipose phenotype, Cell Metabolism, vol. U.S.C. 154(b) by 748 days. 13, pp. 739-748, 2011. Mohammadreza Bozorgmanesh et al., Diabetes prediction, lipid (21) Appl. No.: 13/552,975 accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study, Lipids in Health and Disease, vol. 9, (22) Filed: Jul.19, 2012 pp. 1-9, 2010. Judith Fischer et al., The gene encoding adipose triglyceride lipase (65) Prior Publication Data (PNPLA2) is mutated in neutral lipid storage disease with myopathy, Nature Genetics, vol.39, pp. 28-30, 2007. US 2013/OO23488A1 Jan. 24, 2013 Astrid Gruber et al., The N-terminal region of comparative gene identification-58 (CGI-58) is important for lipid droplet binding and activation of adipose triglyceride lipase, vol. 285, pp. 12289-12298, Related U.S.
    [Show full text]
  • Encyclopedia of Traditional Chinese Medicines - Molecular Structures, Pharmacological Activities, Natural Sources and Applications
    Encyclopedia of Traditional Chinese Medicines - Molecular Structures, Pharmacological Activities, Natural Sources and Applications Vol. 3: Isolated Compounds H-M Bearbeitet von Jiaju Zhou, Guirong Xie, Xinjian Yan 1. Auflage 2011. Buch. xxxi, 669 S. Hardcover ISBN 978 3 642 16746 1 Format (B x L): 21 x 27,9 cm Gewicht: 4190 g Weitere Fachgebiete > Medizin > Sonstige Medizinische Fachgebiete > Pharmakologie, Toxikologie Zu Inhaltsverzeichnis schnell und portofrei erhältlich bei Die Online-Fachbuchhandlung beck-shop.de ist spezialisiert auf Fachbücher, insbesondere Recht, Steuern und Wirtschaft. Im Sortiment finden Sie alle Medien (Bücher, Zeitschriften, CDs, eBooks, etc.) aller Verlage. Ergänzt wird das Programm durch Services wie Neuerscheinungsdienst oder Zusammenstellungen von Büchern zu Sonderpreisen. Der Shop führt mehr als 8 Millionen Produkte. Volume 3 Isolated Compounds (H-M) J. Zhou et al., Encyclopedia of Traditional Chinese Medicines Molecular Structures, Pharmacological Activities, Natural Sources 1 and Applications: Vol. 3: Isolated Compounds H-M, DOI 10.1007/978-3-642-16747-8, © Springer-Verlag Berlin Heidelberg 2011 3 9191 Hainanensine H C17H17NO4 (299.33). Source: HAI NAN CU FEI Cephalotaxus hainanensis [Syn. Cephalotaxus mannii], SAN JIAN SHAN Cephalotaxus fortunei. Ref: 9186 Haemanthamine 660. 25 Hemanthamine [466-75-1] C17H19NO4 (301.35). mp 203~203.5ºC, [α]D = 25 O +19.7º (c = 3.8, methanol), [α]D = +33 (c = 1.25, CHCl3). Pharm: N Antihypertensive (mild); antiretroviral and cytotoxic (ID50 = 0.8μg/mL, TC50 O [5026] = 1.0μg/mL, TI50 (TC50/ID50) = 1.3) . Source: XUE PIAN LIAN O Leucojum vernum (bulb), family Amaryllidaceae spp. Ref: 658, 5026. OH 9192 Hainangenin O C27H44O5 (448.65). Source: JIAN MA Agave sisalana, WU CI FAN MA OH O Agave americana var.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus Chemical Activity Count (+)-ALPHA-VINIFERIN 1 (+)-AROMOLINE 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 2 (+)-ISOLARICIRESINOL 1 (+)-NORTRACHELOGENIN 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-DICENTRINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 4 Chemical Activity Count 1-ETHYL-BETA-CARBOLINE 2 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 16-HYDROXYINGENOL-ESTER 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-VINYL-4H-1,3-DITHIIN 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,3'-DIMETHYLELLAGIC-ACID 1 3,4-DIMETHOXYTOLUENE 2 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 1 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID
    [Show full text]
  • Alkaloids – Secrets of Life
    ALKALOIDS – SECRETS OF LIFE ALKALOID CHEMISTRY, BIOLOGICAL SIGNIFICANCE, APPLICATIONS AND ECOLOGICAL ROLE This page intentionally left blank ALKALOIDS – SECRETS OF LIFE ALKALOID CHEMISTRY, BIOLOGICAL SIGNIFICANCE, APPLICATIONS AND ECOLOGICAL ROLE Tadeusz Aniszewski Associate Professor in Applied Botany Senior Lecturer Research and Teaching Laboratory of Applied Botany Faculty of Biosciences University of Joensuu Joensuu Finland Amsterdam • Boston • Heidelberg • London • New York • Oxford • Paris San Diego • San Francisco • Singapore • Sydney • Tokyo Elsevier Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK First edition 2007 Copyright © 2007 Elsevier B.V. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: [email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Breached Birth
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Breached Birth Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 2 (+)-AROMOLINE 1 (+)-BORNYL-ISOVALERATE 1 (+)-CASSYTHICINE 1 (+)-CATECHIN 2 (+)-CATECHOL 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 2 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 3 (-)-ALPHA-HYDRASTINE 2 (-)-APOGLAZIOVINE 1 (-)-ARGEMONINE 1 (-)-BETONICINE 2 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CENTROLOBINE 1 (-)-DICENTRINE 3 (-)-EPICATECHIN 1 (-)-KAUR-16-EN-19-OIC-ACID 1 (-)-SPARTEINE 2 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 Chemical Activity Count (15:1)-CARDANOL 1 (2Z,8Z)-10-ANGELOYLOXY-MATRICARIA-ESTER 1 (E)-2-HEXENAL 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,2,11,13,2,3'-HEXAHYDROVERNODALIN 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 5 1-MAACKIAIN 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-DIHYDRO-CANTHINE-6-ONE 1 11-HYDROXY-DELTA-8-THC 2 11-HYDROXY-DELTA-9-THC 2 12-ACETYLDEHYDROLUCICULINE 1 13',II8-BIAPIGENIN 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-EPIMETHUENINE 1 16-HYDROXYINGENOL-ESTER 1 2'-HYDROXY-FLAVONE 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-HEXEN-1-OL 1 2-METHOXYPHASEOLLINISOFLAVON 1 2-METHYLBUT-3-ENE-2-OL 2 2-NAPTHOL 1 2 Chemical Activity Count 2-NONANONE 1 2-PROPENE-1-SULFINOTHIOCIC-ACIDS-2-PROPENYL-ESTER
    [Show full text]
  • Prestwick Collection
    (-) -Levobunolol hydrochloride (-)-Adenosine 3',5'-cyclic monophosphate (-)-Cinchonidine (-)-Eseroline fumarate salt (-)-Isoproterenol hydrochloride (-)-MK 801 hydrogen maleate (-)-Quinpirole hydrochloride (+) -Levobunolol hydrochloride (+)-Isoproterenol (+)-bitartrate salt (+,-)-Octopamine hydrochloride (+,-)-Synephrine (±)-Nipecotic acid (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) (cis-) Nanophine (d,l)-Tetrahydroberberine (R) -Naproxen sodium salt (R)-(+)-Atenolol (R)-Propranolol hydrochloride (S)-(-)-Atenolol (S)-(-)-Cycloserine (S)-propranolol hydrochloride 2-Aminobenzenesulfonamide 2-Chloropyrazine 3-Acetamidocoumarin 3-Acetylcoumarin 3-alpha-Hydroxy-5-beta-androstan-17-one 6-Furfurylaminopurine 6-Hydroxytropinone Acacetin Acebutolol hydrochloride Aceclofenac Acemetacin Acenocoumarol Acetaminophen Acetazolamide Acetohexamide Acetopromazine maleate salt Acetylsalicylsalicylic acid Aconitine Acyclovir Adamantamine fumarate Adenosine 5'-monophosphate monohydrate Adiphenine hydrochloride Adrenosterone Ajmalicine hydrochloride Ajmaline Albendazole Alclometasone dipropionate Alcuronium chloride Alexidine dihydrochloride Alfadolone acetate Alfaxalone Alfuzosin hydrochloride Allantoin alpha-Santonin Alprenolol hydrochloride Alprostadil Althiazide Altretamine Alverine citrate salt Ambroxol hydrochloride Amethopterin (R,S) Amidopyrine Amikacin hydrate Amiloride hydrochloride dihydrate Aminocaproic acid Aminohippuric acid Aminophylline Aminopurine, 6-benzyl Amiodarone hydrochloride Amiprilose hydrochloride Amitryptiline hydrochloride
    [Show full text]
  • Biobiopha Cat 1.Xlsx
    BBP No. Chemical Name CAS No. Structure M. F. M. W. Descr. Type O H H N BBP00001 Gelsemine 509-15-9 C20 H22 N2O2 322.4 Powder Alkaloids N O H N H BBP00002 Koumine 1358-76-5 C20 H22 N2O 306.4 Powder Alkaloids H N O H O BBP00003 Humantenmine 82354-38-9 N C19 H22 N2O3 326.4 Cryst. Alkaloids NO O N N H H H BBP00004 Ajmalicine 483-04-5 C21 H24 N2O3 352.4 Cryst. Alkaloids H O O O O OH N BBP00005 Vasicinolone 84847-50-7 C11 H10 N2O3 218.2 Powder Alkaloids N OH O BBP00011 Humantenine 82375-29-9 N C21 H26 N2O3 354.5 Powder Alkaloids NO O OO OH BBP00012 (Z)-Akuammidine 113973-31-2 N C21 H24 N2O3 352.4 Cryst. Alkaloids N H H H N BBP00018 Vasicine 6159-55-3 N C11 H12 N2O 188.2 Powder Alkaloids OH N BBP00023 Vindoline 2182-14-1 H C25 H32 N2O6 456.5 Oil Alkaloids O N OAc H OH COOMe N N H HH BBP00054 Tetrahydroalstonine 6474-90-4 C21 H24 N2O3 352.4 Solid Alkaloids H O O O O OH BBP00058 1H-Indole-3-carboxylic acid 771-50-6 C9H7NO 2 161.2 Powder Alkaloids N H N Pale yellow BBP00061 Canthin-6-one 479-43-6 N C H N O 220.2 Alkaloids 14 8 2 needles O O N BBP00064 Gelsevirine 38990-03-3 C21 H24 N2O3 352.4 Solid Alkaloids NO O + N N BBP00065 Sempervirine 6882-99-1 C19 H16 N2 272.4 Yellow powder Alkaloids OH N BBP00067 Vasicinol 5081-51-6 N C11 H12 N2O2 204.2 Powder Alkaloids OH O H N H BBP60007 Matrine 519-02-8 C15 H24 N2O 248.4 Powder Alkaloids H H N O H N H BBP60008 Oxymatrine 16837-52-8 C15 H24 N2O2 264.4 Powder Alkaloids H H N O OH + N O BBP60009 Jatrorrhizine 3621-38-3 O C20 H20 NO 4 338.4 Yellow powder Alkaloids O O + N O Yellow powder BBP60010 Palmatine
    [Show full text]
  • The University of Chicago Microbially-Regulated
    THE UNIVERSITY OF CHICAGO MICROBIALLY-REGULATED INTESTINAL EPITHELIAL HMGB1: STRESS, CELLULAR ENERGY PRODUCTION AND SURVIVAL A DISSERTATION SUBMITTED TO THE FACULTY OF THE DIVISION OF THE BIOLOGICAL SCIENCES AND THE PRITZKER SCHOOL OF MEDICINE IN CANDIDACY FOR THE DEGREE OF DOCTOR OF PHILOSOPHY COMMITTEE ON MOLECULAR METABOLISM AND NUTRITION BY NOELLE PATNO CHICAGO, ILLINOIS JUNE 2017 Copyright © 2017 by Noelle Patno All rights reserved DEDICATION I dedicate this to Jeannette Messer, Ph.D., and Candace Cham, Ph.D., without whose tireless effort and constant attention to me and my work, this thesis would not have been completed. Table of Contents List of Abbreviations ........................................................................................................ v List of Figures ..................................................................................................................ix List of Tables ................................................................................................................... x List of Appendices ...........................................................................................................xi Acknowledgements ........................................................................................................ xii Abstract ......................................................................................................................... xiv Chapter 1: Introduction ...................................................................................................
    [Show full text]
  • WO 2014/052836 A2 3 April 2014 (03.04.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/052836 A2 3 April 2014 (03.04.2014) P O P C T (51) International Patent Classification: Not classified DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, PCT/US20 13/062309 MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (22) International Filing Date: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 27 September 2013 (27.09.201 3) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (25) Filing Language: English ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 61/706,492 27 September 2012 (27.09.2012) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors; and TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (71) Applicants : DUNMAN, Paul M. [US/US]; 695 W. EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, Bloomfield Road, Pittsford, New York 14534 (US). MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, KRYSAN, Damian J.
    [Show full text]
  • Supplementary File 1
    SUPPLEMENTARY MATERIAL A 50 25 B Control C Control 40 R1881 100nM 20 R1881 100nM 30 15 20 10 Luc F/Luc R F/Luc Luc 10 R F/Luc Luc 5 0 0 ARE(Rad9)Luc + + - - ARE(Rad9)Luc + + - - ARE(pb)Luc - - + + ARE(pb)Luc - - + + PSG5puroMCS2 + - + - PSG5puroMCS2 + - + - PSG5puroMCS2-hAR - + - + PSG5puroMCS2-hARv7 - + - + Supplementary Figure S1. Choice of the AR responsive element and of the AR ligand for the screening assays (A) Comparison of the agonist effect between DHT and R1881 in U2OS- hAR-ARE-Luc cells. Cells were treated with indicated concentrations of the androgens for 16h and AR transactivation was evaluated as described in Materials and Methods. (B, C) Comparison between the Rad9 and the probasin (PB) sequences of the AR responsive element (ARE) for the induction of AR transcriptional activity. U2OS cells were transiently transfected with a plasmid expressing hAR (B) or hARv7 (C), a Firefly luciferase reporter plasmid containing either the Rad9 or the PB ARE and a plasmid expressing the Renilla luciferase. The next day cells were incubated for 16 h in the presence of 100 nM R1881 and the luminescence was quantified. The results were expressed as ratios between the activity of the Firefly luciferase and the Renilla luciferase. 1 A B 150 150 + R1881 0.1nM + R1881 1nM + R1881 0.3nM + R1881 10nM + R1881 1nM 100 100 + R1881 10nM 50 50 % of Luminescence % of Luminescence normalized R1881 10nM R1881 normalized 0 10nM R1881 normalized -8 -7 -6 -5 0 10 10 10 10 10 -8 10 -7 10 -6 10 -5 [Harmol Hydrochloride] (M) [Harmol Hydrochloride] (M) Supplementary Figure S2.
    [Show full text]